☰

Juan L. Mendoza - Publications

Affiliations: 
University of Chicago, Chicago, IL 
Area:
Structural biology, protein engineering, immunology, drug design
Tree Info Similar researchers PubMed Report error

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Mendoza JL, Fischer S, Gee MH, Lam LH, Brackenridge S, Powrie FM, Birnbaum M, McMichael AJ, Garcia KC, Gillespie GM. Interrogating the recognition landscape of a conserved HIV-specific TCR reveals distinct bacterial peptide cross-reactivity. Elife. 9. PMID 32716298 DOI: 10.7554/Elife.58128  0.718
2020 Mendoza JL, Fischer S, Gee MH, Lam LH, Brackenridge S, Powrie FM, Birnbaum M, McMichael AJ, Garcia KC, Gillespie GM. Author response: Interrogating the recognition landscape of a conserved HIV-specific TCR reveals distinct bacterial peptide cross-reactivity Elife. DOI: 10.7554/Elife.58128.Sa2  0.694
2019 Mendoza JL, Escalante NK, Jude KM, Sotolongo Bellon J, Su L, Horton TM, Tsutsumi N, Berardinelli SJ, Haltiwanger RS, Piehler J, Engleman EG, Garcia KC. Structure of the IFNγ receptor complex guides design of biased agonists. Nature. PMID 30814731 DOI: 10.1038/S41586-019-0988-7  0.54
2018 Pervolaraki K, Rastgou Talemi S, Albrecht D, Bormann F, Bamford C, Mendoza JL, Garcia KC, McLauchlan J, Höfer T, Stanifer ML, Boulant S. Differential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundance. Plos Pathogens. 14: e1007420. PMID 30485383 DOI: 10.1371/Journal.Ppat.1007420  0.479
2018 Illing PT, Pymm P, Croft NP, Hilton HG, Jojic V, Han AS, Mendoza JL, Mifsud NA, Dudek NL, McCluskey J, Parham P, Rossjohn J, Vivian JP, Purcell AW. HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome. Nature Communications. 9: 4693. PMID 30410026 DOI: 10.1038/S41467-018-07109-W  0.414
2018 Bamford CGG, Aranday-Cortes E, Filipe IC, Sukumar S, Mair D, Filipe ADS, Mendoza JL, Garcia KC, Fan S, Tishkoff SA, McLauchlan J. A polymorphic residue that attenuates the antiviral potential of interferon lambda 4 in hominid lineages. Plos Pathogens. 14: e1007307. PMID 30308076 DOI: 10.1371/Journal.Ppat.1007307  0.438
2018 Riley TP, Hellman LM, Gee MH, Mendoza JL, Alonso JA, Foley KC, Nishimura MI, Vander Kooi CW, Garcia KC, Baker BM. T cell receptor cross-reactivity expanded by dramatic peptide-MHC adaptability. Nature Chemical Biology. 14: 934-942. PMID 30224695 DOI: 10.1038/S41589-018-0130-4  0.581
2018 Gee MH, Sibener LV, Birnbaum ME, Jude KM, Yang X, Fernandes RA, Mendoza JL, Glassman CR, Garcia KC. Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcro. Proceedings of the National Academy of Sciences of the United States of America. PMID 30021852 DOI: 10.1073/Pnas.1802746115  0.725
2017 Gee MH, Han A, Lofgren SM, Beausang JF, Mendoza JL, Birnbaum ME, Bethune MT, Fischer S, Yang X, Gomez-Eerland R, Bingham DB, Sibener LV, Fernandes RA, Velasco A, Baltimore D, et al. Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell. PMID 29275860 DOI: 10.1016/J.Cell.2017.11.043  0.713
2017 Hilton HG, McMurtrey CP, Han AS, Djaoud Z, Guethlein LA, Blokhuis JH, Pugh JL, Goyos A, Horowitz A, Buchli R, Jackson KW, Bardet W, Bushnell DA, Robinson PJ, Mendoza JL, et al. The Intergenic Recombinant HLA-B∗46:01 Has a Distinctive Peptidome that Includes KIR2DL3 Ligands. Cell Reports. 19: 1394-1405. PMID 28514659 DOI: 10.1016/J.Celrep.2017.04.059  0.671
2017 Moraga I, Spangler JB, Mendoza JL, Gakovic M, Wehrman TS, Krutzik P, Garcia KC. Synthekines are surrogate cytokine and growth factor agonists that compel signaling through non-natural receptor dimers. Elife. 6. PMID 28498099 DOI: 10.7554/Elife.22882  0.69
2017 Mendoza JL, Schneider WM, Hoffmann HH, Vercauteren K, Jude KM, Xiong A, Moraga I, Horton TM, Glenn JS, de Jong YP, Rice CM, Garcia KC. The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity. Immunity. 46: 379-392. PMID 28329704 DOI: 10.1016/J.Immuni.2017.02.017  0.495
2017 Moraga I, Spangler JB, Mendoza JL, Gakovic M, Wehrman TS, Krutzik P, Garcia KC. Author response: Synthekines are surrogate cytokine and growth factor agonists that compel signaling through non-natural receptor dimers Elife. DOI: 10.7554/Elife.22882.019  0.671
2017 Riley TP, Mendoza J, Garcia KC, Baker BM. 2064 Journal of Clinical and Translational Science. 1: 54-55. DOI: 10.1017/cts.2017.195  0.522
2016 Ng CT, Mendoza JL, Garcia KC, Oldstone MB. Alpha and Beta Type 1 Interferon Signaling: Passage for Diverse Biologic Outcomes. Cell. 164: 349-352. PMID 26824652 DOI: 10.1016/J.Cell.2015.12.027  0.452
2015 Spangler JB, Moraga I, Mendoza JL, Garcia KC. Insights into cytokine-receptor interactions from cytokine engineering. Annual Review of Immunology. 33: 139-67. PMID 25493332 DOI: 10.1146/Annurev-Immunol-032713-120211  0.682
2014 Birnbaum ME, Mendoza JL, Sethi DK, Dong S, Glanville J, Dobbins J, Ozkan E, Davis MM, Wucherpfennig KW, Garcia KC. Deconstructing the peptide-MHC specificity of T cell recognition. Cell. 157: 1073-87. PMID 24855945 DOI: 10.1016/J.Cell.2014.03.047  0.742
2014 Moraga I, Spangler J, Mendoza JL, Garcia KC. Multifarious determinants of cytokine receptor signaling specificity. Advances in Immunology. 121: 1-39. PMID 24388212 DOI: 10.1016/B978-0-12-800100-4.00001-5  0.701
2012 Mendoza JL, Schmidt A, Li Q, Nuvaga E, Barrett T, Bridges RJ, Feranchak AP, Brautigam CA, Thomas PJ. Requirements for efficient correction of ΔF508 CFTR revealed by analyses of evolved sequences. Cell. 148: 164-74. PMID 22265409 DOI: 10.1016/J.Cell.2011.11.023  0.526
2012 Zhu L, Millen L, Mendoza J, Thomas P. 1.270 A UNIQUE REDOX-SENSING SENSOR-II MOTIF IN TORSINA PLAYS A CRITICAL ROLE IN NUCLEOTIDE AND PARTNER BINDING Parkinsonism & Related Disorders. 18: S64. DOI: 10.1016/S1353-8020(11)70328-5  0.426
2011 Schmidt A, Mendoza JL, Thomas PJ. Biochemical and biophysical approaches to probe CFTR structure. Methods in Molecular Biology (Clifton, N.J.). 741: 365-76. PMID 21594797 DOI: 10.1007/978-1-61779-117-8_24  0.524
2011 Mendoza JL, Schmidt A, Thomas PJ. Introduction to section IV: biophysical methods to approach CFTR structure. Methods in Molecular Biology (Clifton, N.J.). 741: 321-7. PMID 21594794 DOI: 10.1007/978-1-61779-117-8_21  0.513
2011 Thomas P, Mendoza JL, Schmidt A, Millen L. Mutations that Disrupt Formation of Functional CFTR Biophysical Journal. 100. DOI: 10.1016/J.Bpj.2010.12.2177  0.526
2010 Zhu L, Millen L, Mendoza JL, Thomas PJ. A unique redox-sensing sensor II motif in TorsinA plays a critical role in nucleotide and partner binding. The Journal of Biological Chemistry. 285: 37271-80. PMID 20861018 DOI: 10.1074/Jbc.M110.123471  0.523
2010 Thibodeau PH, Richardson JM, Wang W, Millen L, Watson J, Mendoza JL, Du K, Fischman S, Senderowitz H, Lukacs GL, Kirk K, Thomas PJ. The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis. The Journal of Biological Chemistry. 285: 35825-35. PMID 20667826 DOI: 10.1074/Jbc.M110.131623  0.513
2007 Mendoza JL, Thomas PJ. Building an understanding of cystic fibrosis on the foundation of ABC transporter structures. Journal of Bioenergetics and Biomembranes. 39: 499-505. PMID 18080175 DOI: 10.1007/S10863-007-9117-7  0.506
Show low-probability matches.